Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection
Clinical trial NCT04308278 · RECRUITING
Trial details
- NCT number
- NCT04308278
- Sponsor
- Labo'Life
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-22
- Primary completion
- 2026-08-22
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.